Good Lifestyle

The Food and Drug Administration drug shortage listing Thursday, it became a little longer, like the Mounjaro, Eli Lilly and Co, a new popular Diabetes Injectable, and Trulicity, another drug against diabetes by the same company, have been identified as low Reuters .

This growing list of drug shortages is a reminder that gives reflection that the procurement shortages exacerbated by the world pandemic, and a high demand for drugs due to an increasing number of diseases, such as RSV and Streptococlace, disturb always people's lives and compromise their health.

"The drug shortages can constitute a significant threat to public health because they can cause delayed treatment for patients, the rationing of drugs and, in some cases, the treatment is refused due to the lack of significant drugs", explains the Mayo clinic .

Regarding Mounjaro in particular, the FDA stressed that the "dynamic nature of this new product launch" - it comes at many doses - makes sensitivity to shortages. However, some doses remain available. AE0FCC31AE342FD3A1346EBB1F342FCB

RELATED: 4 medication exchanges to ask your doctor now

"We expect to see intermittent delays in wholesalers and pharmacies to receive doses of Mounjaro," said director Anat Ashkenazi at a conference call with analysts on Tuesday, December 13.

Recent drug shortages worry patients and professionals

Drug shortages are reported all over the world. Companies like Teva, Hikma Pharmaceuticals and Sandoz have reported shortages of key brands.

Some antibiotics, cancer drugs and emergency care drugs are all faced with stockings. Tamiflu ran low in Utah, for example.

The drug shortages are "not new" but "increased", explains the expert

There may be various reasons for the shortage of drugs. Some common causes include:

1. Manufacturing delays or production problems: These can be caused by problems such as quality control problems in a manufacturing installation, shortages of raw materials or an unexpected increase in demand.
2. Disturbances of the supply chain: Natural disasters, transport delays or other logistical problems can disrupt the supply chain and make it difficult to disseminate drugs where they are necessary.
3. Limited competition: If there are only a few manufacturers who produce a particular medication, a problem in one of these facilities can cause a shortage.
4. Demand changes: Sudden changes in demand for a particular medication, as we could see during a pandemic, can lead to shortages.
5. Regulatory issues: Sometimes regulatory problems can cause delays in the production or distribution of medicines.

It should be noted that drug shortages are not a new phenomenon and have been performing for many years. However, the COVVI-19 pandemic exacerbated the existing shortages and caused new ones.

"The drug shortages are not new in health care, but really in the past two years with the COVVI-19 pandemic, these shortages have really revealed the vulnerability of our world supply chain," said Dr. Mary Gilmer , director of pharmaceutical supply and purchases for Mayo Midwest, in a round table held this summer.

"And these drug shortages continue to remain raised despite decades of continuous and increased awareness, efforts and significant investment on resources in these drug shortage programs at the highest level."

As for why it happens exactly, it said: "They include the considerations and challenges of supply and demand, and we have seen with natural and natural disasters such as hurricanes, including manufacturing problems … This could be the shortage of raw materials or even the challenges of the endowment that manufacturing factories know as a result of the pandemic. And then, we cannot certainly ignore any type of trade and regulatory changes due to the analysis of the analysis profit or market where manufacturers can decide to end a product. "

"There are high levels of stress and frustration for all people involved when it treats shortages," she added.